Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

EUROMEDICAT

Financiado

Cerrado

EUROmediCAT Safety of Medication use in Pregnancy in Relation to Risk of Congen...

EUROmediCAT Safety of Medication use in Pregnancy in Relation to Risk of Congenital Malformations A variety of complementary approaches are needed to evaluate safety of medicine use in pregnancy. To evaluate safety in relation to teratogenicity (capacity to cause malformations), population-based congenital anomaly registers, w... ver más

28/02/2015

Ulster

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

UNIVERSITY OF ULSTER No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 9 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2015-02-28 No tenemos la información de la convocatoria

0% 76% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

9 Participantes

Ulster

0.00€ | Lider

RIJKSUNIVERSITEIT GRONINGEN

N.D. | Participante

QMUL

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PROTECT Pharmacoepidemiolocal Research on Outcomes of Therapeutics b... 29M€ Cerrado

EUROlinkCAT EUROlinkCAT Establishing a linked European Cohort of Childr... 7M€ Cerrado

EU-ADR Exploring and understanding adverse drug reactions by integr... 6M€ Cerrado

ConcePTION Building an ecosystem for better monitoring and communicatin... 29M€ Cerrado

BIO2014-54404-R APROXIMACIONES DE SISTEMAS A LA PREDICCION AVANZADA DE LA SE... 109K€ Cerrado

PhilPharm Philosophy of Pharmacology Safety Statistical standards an... 2M€ Cerrado

Líder del proyecto

UNIVERSITY OF ULSTER No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 4M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto A variety of complementary approaches are needed to evaluate safety of medicine use in pregnancy. To evaluate safety in relation to teratogenicity (capacity to cause malformations), population-based congenital anomaly registers, which are already networked across Europe (EUROCAT) with a common database, can provide a cost-effective mechanism which is as yet underexploited. The enormous population coverage of registers when combined gives sufficient statistical power for the identification of associations between specific drugs and specific malformations. This project will develop and test an efficient pharmaco-vigilance system for safety of drugs during pregnancy in relation to teratogenicity by (i) enhancing the information regarding drug exposure in the EUROCAT database, covering a total population of 3 million births 1995-2010, through linkage to electronic databases containing prescription information, and by linkage to chronic disease cohorts (ii) analysing the enhanced EUROCAT database in relation to four drug groups of public health concern - new antiepileptics, insulin analogs, SSRI antidepressants, and antiasthmatics - exposure to all of which is increasing in the pregnant population (iii) interrogating health care databases to monitor the effectiveness of drug safety recommendations and pregnancy prevention programmes through drug utilisation studies, and to provide an exposure profile for pregnant women (iv) conducting a scoping study of the implications for drug safety of growing internet use by pregnant women, in terms of access to safety information about teratogenicity, and access to drugs with teratogenic potential.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores